SIGNIFICATION OF MAGNESIUM IN THERAPY OF CARDIOVASCULAR DISEASES

<p>Cardiovascular diseases are one of the most significant social-medical problems. Having on mind their importance, the risk factors have been defined. Numerous clinical and epidemiological studies showed that deficit of magnesium in the human organism has a certain contribution in etiology, pathogenesis and evolution of cardiovascular diseases. RASKO, Rakovica's study of cardiovascular diseases, found out that these diseases are more frequent at the locations where<br />soft water with decreased content of magnesium is being used as drinking water. Magnesium is an integral part of about 300 enzyme systems in which catalyst's role have adenositriphospathase as Mg-ATP, a part of NaKATP-ase, exogenous and endogenous pumps for calcium, etc. A normal plasmatic concentration of magnesium is 0,8-1 mmol/l. Plasmatic level of magnesium is not directly correlated with actually content in an organism since 33% of plasmatic magnesium is connected with plasma's proteins and that's why hypoproteinemia can cause a false hypomagnesemia. The normal values of magnesemia don't exclude deficit of magnesium in an organism since PTH and calcitonin mobilize magnesium from the bones. Hypomegnesemia is caused by improper and irrational nutrition, hormone disturbances, and different conditions and diseases of an organism. Magnesium has vasodiletatoric, antianginosic, hypolipemic, antiagregatic effects. Mechanism of magnesium's effect is based on its physiological role in an organism, i.e. on correction of hypomagnesemia. In preventive and therapeutic purposes magnesium's compounds are used peroraly and parenteraly. With parenteral use the plasmatic concentrations of more than physiological 2,5-7,5 mEq/l can be attained in which case somnolentia can be appeared but not a coma nor depression of breathing. In prevention and therapy of cardiovascular diseases magnesium has a significant place in the largest number of cases as an adjuvant drug</p>